Multicenter Selective Lymphadenectomy Trial-I confirms the central role of sentinel node biopsy in contemporary melanoma management: Response to ‘No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report’

Ähnliche Einträge

• Sentinel-Node Biopsy in Melanoma
  von: Thompson, John F., et al.
  Veröffentlicht: (2014)
• Sentinel Node Biopsy for Early-Stage Melanoma: Accuracy and Morbidity in MSLT-I, an International Multicenter Trial
  von: Morton, Donald L., et al.
  Veröffentlicht: (2005)
• Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
  von: Morton, D.L., et al.
  Veröffentlicht: (2014)
• The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)
  von: Faries, Mark B., et al.
  Veröffentlicht: (2010)
• Sentinel Lymph Node Biopsy for Melanoma: A Plea to Let the Data be Heard
  von: Thompson, John F., et al.
  Veröffentlicht: (2014)